Angiogenesis is inhibited and the growth of tumors is treated by administering an effective amount of a PPAR gamma ligand/agonist, optionally with an RXR receptor ligand.

 
Web www.patentalert.com

< Pyrrolo-pyridine kinase modulators

< Heteroaryl urea neuropeptide Y Y5 receptor antagonists

> Compounds for the reduction of excessive food intake

> Indole, indazole and indoline derivatives as CETP inhibitors
~ 00237